Could boron compounds be effective against SARS-CoV-2?

被引：14

作者：

Ataseven, H. ^{[1
]}

Sayin, K. ^{[2
]}

Tuzun, B. ^{[3
]}

Gedikli, M. A. ^{[4
]}

机构：

[1] Sivas Cumhuriyet Univ, Dept Gastroenterol, Fac Med, Sivas, Turkey

[2] Sivas Cumhuriyet Univ, Fac Sci, Dept Chem, Sivas, Turkey

[3] Sivas Cumhuriyet Univ, Plantal & Anim Prod Dept, Sivas Tech Sci Vocat Sch, Sivas, Turkey

[4] Sivas Cumhuriyet Univ, Fac Med, Dept Internal Med, Sivas, Turkey

来源：

BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY | 2021年 / 122卷 / 10期

关键词：

boronate ester; dioxaborole; in silico; SARS-CoV-2; MD calculations; DOCKING; GLIDE;

D O I：

10.4149/BLL_2021_121

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

BACKGROUND: Seven dioxaborole compounds are investigated in this study. Structural and spectral characterization is done at M062X/6-31+G(d,p) level in the water. Active sites of these compounds are determined using molecular electrostatic potential (MEP) maps. Electrophilic and nucleophilic attack regions are determined. AIM: We aimed to determine whether Boron-Containing Compounds (BCCs) inhibitor used in the treatment of COVID-19 are effective against SARS Cov-2 in silico. RESULTS AND CONCLUSION: Since SARS-CoV-2 is a worldwide health problem, anti-viral properties of studied boron-containing compounds were investigated by molecular docking calculations. In addition to these calculations, MM/PSBA calculations were performed. It was found that boron compounds can be good drug candidate against SARS-CoV-2 and the best compound is ((R)-1-((S)-3-(4-(aminomethyl)phenyl)-2-benzamidopropanamido)-4-guanidinobutyl)boronic acid (C26).

引用

页码：753 / 758

页数：6

共 29 条

[1] How do arbidol and its analogs inhibit the SARS-CoV-2? [J].

Aktas, A. ;

Tuzun, B. ;

Kafa, Taskin A. H. ;

Sayin, K. ;

Ataseven, H. .

BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2020, 121 (10) :705-711

[2]

Aktas A, AGE, V54, P18

[3] New anti-viral drugs for the treatment of COVID-19 instead of favipiravir [J].

Aktas, Ahmet ;

Tuzun, Burak ;

Aslan, Rukiye ;

Sayin, Koray ;

Ataseven, Hilmi .

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (18) :7263-7273

[4]

[Anonymous], 2019, RELEASE S 3 MAESTRO

[5] Geographic Differences in COVID-19 Cases, Deaths, and Incidence - United States, February 12-April 7, 2020 [J].

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2020, 69 (15) :465-471

[6] Could boron-containing compounds (BCCs) be effective against SARS-CoV-2 as anti-viral agent? [J].

Cetiner, E. ;

Sayin, K. ;

Tuzun, B. ;

Ataseven, H. .

BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2021, 122 (04) :263-269

[7]

Dennington II R.D., 2009, GAUSSVIEW 5 0

[8] Discovering drugs to treat coronavirus disease 2019 (COVID-19) [J].

Dong, Liying ;

Hu, Shasha ;

Gao, Jianjun .

DRUG DISCOVERIES AND THERAPEUTICS, 2020, 14 (01) :58-60

[9] Current data regarding the structure-toxicity relationship of boron-containing compounds [J].

Farfan-Garcia, E. D. ;

Castillo-Mendieta, N. T. ;

Cipres-Floresa, F. J. ;

Padilla-Martinez, I. I. ;

Trujillo-Ferrara, J. G. ;

Soriano-Ursua, M. A. .

TOXICOLOGY LETTERS, 2016, 258 :115-125

[10]

Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI [10.3760/cma.j.issn.0254-6450.2020.02.003, 10.46234/ccdcw2020.032]

← 1 2 3 →